Please assess the completion status of the following clinical trial:

Trial Title: Study to Evaluate Ospemifene in Patients With Moderate to Severe Vaginal Dryness Due to Menopause

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: TRIPLE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Subject is postmenopausal.~* Subject has moderate to severe vaginal dryness as the self-reported MBS of VVA.~Exclusion Criteria:~* Subject has clinically significant abnormal findings in the physical examination.~* Subject has a body mass index (BMI) equal to or greater than 38 kg/m\^2~* Subject has uncontrolled hypertension.~* Subject has clinically significant abnormal findings in the gynecological examination other than signs of vaginal atrophy.~* Subject has uterine/vaginal bleeding of unknown origin.~* Subject has a vaginal infection requiring medication (may be treated and be eligible for study).

- Gender: FEMALE
- Minimum Age: 40 Years
- Maximum Age: 80 Years
- Healthy Volunteers: f

Study Arms:
- Ospemifene (Type: EXPERIMENTAL): Participants will take one tablet of ospemifene 60 mg orally, once a day for 12 weeks.
- Placebo (Type: PLACEBO_COMPARATOR): Participants will take one tablet of matching placebo, orally, once a day for 12 weeks.

Based on this trial design, predict the completion outcome and termination type (if applicable).